View Item 

Show simple item record

Low Serum Hepcidin Is Associated With Reduced Shortâ Term Survival in Adults With Acute Liver Failure
dc.contributor.authorSpivak, Igor
dc.contributor.authorArora, Jyoti
dc.contributor.authorMeinzer, Caitlyn
dc.contributor.authorDurkalski‐mauldin, Valerie
dc.contributor.authorLee, William M.
dc.contributor.authorTrautwein, Christian
dc.contributor.authorFontana, Robert J.
dc.contributor.authorStrnad, Pavel
dc.date.accessioned2019-05-31T18:26:42Z
dc.date.available2020-07-01T17:47:46Zen
dc.date.issued2019-05
dc.identifier.citationSpivak, Igor; Arora, Jyoti; Meinzer, Caitlyn; Durkalski‐mauldin, Valerie ; Lee, William M.; Trautwein, Christian; Fontana, Robert J.; Strnad, Pavel (2019). "Low Serum Hepcidin Is Associated With Reduced Shortâ Term Survival in Adults With Acute Liver Failure." Hepatology (5): 2136-2149.
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://hdl.handle.net/2027.42/149282
dc.publisherWiley Periodicals, Inc.
dc.titleLow Serum Hepcidin Is Associated With Reduced Shortâ Term Survival in Adults With Acute Liver Failure
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149282/1/hep30486_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149282/2/hep30486.pdf
dc.identifier.doi10.1002/hep.30486
dc.identifier.sourceHepatology
dc.identifier.citedreferenceDarveau M, Denault AY, Blais N, Notebaert E. Benchâ toâ bedside review: iron metabolism in critically ill patients. Crit Care 2004; 8: 356 â 362.
dc.identifier.citedreferenceSangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin. Adv Nutr 2017; 8: 126 â 136.
dc.identifier.citedreferenceMaras JS, Maiwall R, Harsha HC, Das S, Hussain S, Kumar C, et al. Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acuteâ onâ chronic liver failure. Hepatology 2015; 61: 1306 â 1320.
dc.identifier.citedreferenceBruns T, Nuraldeen R, Mai M, Stengel S, Zimmermann HW, Yagmur E, et al. Low serum transferrin correlates with acuteâ onâ chronic organ failure and indicates shortâ term mortality in decompensated cirrhosis. Liver Int 2017; 37: 232 â 241.
dc.identifier.citedreferenceViveiros A, Finkenstedt A, Schaefer B, Mandorfer M, Scheiner B, Lehner K, et al. Transferrin as a predictor of survival in cirrhosis. Liver Transpl 2018; 24: 343 â 351.
dc.identifier.citedreferenceMaiwall R, Kumar S, Chaudhary AK, Maras J, Wani Z, Kumar C, et al. Serum ferritin predicts early mortality in patients with decompensated cirrhosis. J Hepatol 2014; 61: 43 â 50.
dc.identifier.citedreferenceNahon P, Nuraldeen R, Rufat P, Sutton A, Trautwein C, Strnad P. In alcoholic cirrhosis, lowâ serum hepcidin levels associate with poor longâ term survival. Liver Int 2016; 36: 185 â 188.
dc.identifier.citedreferenceMossanen JC, Tacke F. Acetaminophenâ induced acute liver injury in mice. Lab Anim 2015; 49: 30 â 36.
dc.identifier.citedreferenceTacke F, Nuraldeen R, Koch A, Strathmann K, Hutschenreuter G, Trautwein C, et al. Iron parameters determine the prognosis of critically ill patients. Crit Care Med 2016; 44: 1049 â 1058.
dc.identifier.citedreferenceBhagat CI, Fletcher S, Joseph J, Beilby JP. Plasma ferritin in acute hepatocellular damage. Clin Chem 2000; 46: 885 â 886.
dc.identifier.citedreferenceAwai M, Brown EB. Studies of the metabolism of Iâ 131â labeled human transferrin. J Clin Lab Med 1963; 61: 363 â 396.
dc.identifier.citedreferenceRitchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acuteâ phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999; 13: 273 â 279.
dc.identifier.citedreferenceBrissot P, Ropert M, Le Lan C, Loréal O. Nonâ transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 2012; 1820: 403 â 410.
dc.identifier.citedreferenceKoskenkorvaâ Frank TS, Weiss G, Koppenol WH, Burckhardt S. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med 2013; 65: 1174 â 1194.
dc.identifier.citedreferenceSingal AK, Jampana SC, Weinman SA. Antioxidants as therapeutic agents for liver disease. Liver Int 2011; 31: 1432 â 1448.
dc.identifier.citedreferenceZider AD, Zopey R, Garg R, Wang X, Wang TS, Deng JC. Prognostic significance of infections in critically ill adult patients with acute liver injury: a retrospective cohort study. Liver Int 2016; 36: 1143 â 1150.
dc.identifier.citedreferencePotaznik D, Groshen S, Miller D, Bagin R, Bhalla R, Schwartz M, et al. Association of serum iron, serum transferrin saturation, and serum ferritin with survival in acute lymphocytic leukemia. Am J Pediatr Hematol Oncol 1987; 9: 350 â 355.
dc.identifier.citedreferenceTan TC, Crawford DH, Franklin ME, Jaskowski LA, Macdonald GA, Jonsson JR, et al. The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver Int 2012; 32: 1391 â 1399.
dc.identifier.citedreferenceGirelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood 2016; 127: 2809 â 2813.
dc.identifier.citedreferenceRivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid doseâ dependent hypoferremia and is concentrated in ferroportinâ containing organs. Blood 2005; 106: 2196 â 2199.
dc.identifier.citedreferenceGalesloot TE, Vermeulen SH, Geurtsâ Moespot AJ, Klaver SM, Kroot JJ, van Tienoven D, et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011; 117: 218 â 225.
dc.identifier.citedreferenceReuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study. Ann Intern Med 2016; 164: 724 â 732.
dc.identifier.citedreferenceDonnelly MC, Hayes PC, Simpson KJ. The changing face of liver transplantation for acute liver failure: assessment of current status and implications for future practice. Liver Transpl 2016; 22: 527 â 535.
dc.identifier.citedreferenceWendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Samuel D, et al. EASL Clinical Practical Guidelines on the Management of Acute (Fulminant) Liver Failure. J Hepatol 2017; 66: 1047 â 1081.
dc.identifier.citedreferenceFlamm SL, Yang YX, Singh S, Falckâ Ytter YT, Flamm SL, Lim JK, et al. American Gastroenterological Association Institute Guidelines for the Diagnosis and Management of Acute Liver Failure. Gastroenterology 2017; 152: 644 â 647.
dc.identifier.citedreferenceMcPhail MJ, Farne H, Senvar N, Wendon JA, Bernal W. Ability of King’s College Criteria and Model for Endâ Stage Liver Disease scores to predict mortality of patients with acute liver failure: a metaâ analysis. Clin Gastroenterol Hepatol 2016; 14: 516 â 525.
dc.identifier.citedreferenceRutherford A, King LY, Hynan LS, Vedvyas C, Lin W, Lee WM, et al. Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology 2012; 143: 1237 â 1243.
dc.identifier.citedreferenceKoch DG, Tillman H, Durkalski V, Lee WM, Reuben A. Development of a model to predict transplantâ free survival of patients with acute liver failure. Clin Gastroenterol Hepatol 2016; 14: 1199 â 1206.
dc.identifier.citedreferenceStutchfield BM, Antoine DJ, Mackinnon AC, Gow DJ, Bain CC, Hawley CA, et al. CSF1 restores innate immunity after liver injury in mice and serum levels indicate outcomes of patients with acute liver failure. Gastroenterology 2015; 149: 1896 â 1909.
dc.identifier.citedreferenceKamath PS, Heimbach J, Wiesner RH. Acute liver failure prognostic scores: is good enough good enough? Clin Gastroenterol Hepatol 2016; 14: 621 â 623.
dc.identifier.citedreferenceKarvellas CJ, Speiser JL, Tremblay M, Lee WM, Rose CF. Elevated FABP1 serum levels are associated with poorer survival in acetaminophenâ induced acute liver failure. Hepatology 2017; 65: 938 â 949.
dc.identifier.citedreferenceAnastasiou OE, Kälsch J, Hakmouni M, Kucukoglu O, Heider D, Korth J, et al. Low transferrin and high ferritin concentrations are associated with worse outcome in acute liver failure. Liver Int 2017; 37: 1032 â 1041.
dc.identifier.citedreferenceGanz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol 2015; 15: 500 â 510.
dc.identifier.citedreferencePietrangelo A. Iron and the liver. Liver Int 2016; 36 ( Suppl 1 ): 116 â 123.
dc.identifier.citedreferenceCamaschella C. Ironâ deficiency anemia. N Engl J Med 2015; 372: 1832 â 1843.
dc.identifier.citedreferenceRishi G, Subramaniam VN. The liver in regulation of iron homeostasis. Am J Physiol Gastrointest Liver Physiol 2017; 313: 157 â 165.
dc.identifier.citedreferenceRuchala P, Nemeth E. The pathophysiology and pharmacology of hepcidin. Trends in Pharmacol Sci 2014; 35: 155 â 161.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep30486_am.pdf
Size:
399.4KB
Format:
PDF
View/Open
Name:
hep30486.pdf
Size:
491.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.